Mark A. Watson

29.9k total citations
129 papers, 7.2k citations indexed

About

Mark A. Watson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mark A. Watson has authored 129 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 49 papers in Oncology and 37 papers in Cancer Research. Recurrent topics in Mark A. Watson's work include Cancer Cells and Metastasis (21 papers), Cancer Genomics and Diagnostics (19 papers) and Molecular Biology Techniques and Applications (14 papers). Mark A. Watson is often cited by papers focused on Cancer Cells and Metastasis (21 papers), Cancer Genomics and Diagnostics (19 papers) and Molecular Biology Techniques and Applications (14 papers). Mark A. Watson collaborates with scholars based in United States, Canada and France. Mark A. Watson's co-authors include Jeffrey Milbrandt, Timothy P. Fleming, David H. Gutmann, Arie Perry, Rakesh Nagarajan, Toshiyuki Araki, John Svaren, Torsten Ehrig, Verónica Luzzi and Peter A. Humphrey and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mark A. Watson

123 papers receiving 7.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Watson United States	48	3.4k	1.9k	1.7k	1.4k	794	129	7.2k
Nicolás André France	50	4.1k 1.2×	2.8k 1.5×	1.8k 1.1×	1.2k 0.8×	643 0.8×	264	8.6k
Yusuke Nakamura Japan	54	4.6k 1.3×	2.1k 1.1×	1.5k 0.9×	1.1k 0.7×	1.3k 1.6×	160	10.4k
Athanassios P. Kyritsis United States	48	3.2k 0.9×	2.0k 1.1×	1.1k 0.6×	1.5k 1.1×	480 0.6×	173	7.9k
Barry D. Nelkin United States	52	5.1k 1.5×	2.7k 1.4×	899 0.5×	921 0.6×	641 0.8×	110	8.2k
Qin Huang United States	47	3.1k 0.9×	1.9k 1.0×	1.1k 0.6×	1.4k 1.0×	819 1.0×	288	7.6k
Olle Larsson Sweden	51	4.4k 1.3×	2.5k 1.3×	1.3k 0.8×	2.2k 1.6×	818 1.0×	212	8.5k
Viji Shridhar United States	47	4.5k 1.3×	1.4k 0.7×	1.4k 0.8×	643 0.5×	367 0.5×	126	7.2k
Vladimir Lazar France	46	4.1k 1.2×	2.1k 1.1×	2.1k 1.2×	954 0.7×	607 0.8×	133	7.4k
Carl Morrison United States	45	4.2k 1.2×	2.3k 1.2×	2.4k 1.4×	1.3k 0.9×	922 1.2×	185	8.1k
Kristin Waite United States	38	3.9k 1.1×	1.4k 0.7×	1.7k 1.0×	1.7k 1.2×	471 0.6×	103	10.0k

Countries citing papers authored by Mark A. Watson

Since Specialization

Citations

This map shows the geographic impact of Mark A. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Watson more than expected).

Fields of papers citing papers by Mark A. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Watson. The network helps show where Mark A. Watson may publish in the future.

Co-authorship network of co-authors of Mark A. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Watson. A scholar is included among the top collaborators of Mark A. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Watson. Mark A. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Metzger, Otto, Karla V. Ballman, Minetta C. Liu, et al.. (2025). Adjuvant Dose-Dense Chemotherapy in Hormone Receptor–Positive Breast Cancer. Journal of Clinical Oncology. 43(10). 1229–1239. 1 indexed citations

Izmirly, Abdullah M., Mark A. Watson, Tiziana Di Pucchio, et al.. (2024). A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine. Cell Reports. 43(7). 114370–114370.

Stover, Daniel G., Roberto Salgado, Karla V. Ballman, et al.. (2024). Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502. npj Breast Cancer. 10(1). 75–75. 4 indexed citations

Watson, Mark A., Cory T. Bernadt, Steven H. Lin, et al.. (2024). AI ‐guided histopathology predicts brain metastasis in lung cancer patients. The Journal of Pathology. 263(1). 89–98. 13 indexed citations

Shen, Cheng, Siddarth Rawal, Ashutosh Agarwal, et al.. (2023). Automatic detection of circulating tumor cells and cancer associated fibroblasts using deep learning. Scientific Reports. 13(1). 5708–5708. 19 indexed citations

Pehrsson, Erica C., Xiaoyun Xing, Mark A. Watson, et al.. (2023). Non-Small Cell Lung Cancer Epigenomes Exhibit Altered DNA Methylation in Smokers and Never-Smokers. Genomics Proteomics & Bioinformatics. 21(5). 991–1013. 7 indexed citations

Baer, John, Brett L. Knolhoff, Graham D. Hogg, et al.. (2023). Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer. Cancer Immunology Research. 11(8). 1055–1067. 13 indexed citations

Devarakonda, Siddhartha, Xiaoyun Xing, H. Josh Jang, et al.. (2022). Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis. Cancer Research. 82(15). 2692–2703. 13 indexed citations

Arthur, Laura, Ekaterina Esaulova, Denis A. Mogilenko, et al.. (2021). Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging. Nature Aging. 1(6). 535–549. 30 indexed citations

10.

Cynthia, X., Vera J. Suman, A. Marilyn Leitch, et al.. (2020). ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106.. Journal of Clinical Oncology. 38(15_suppl). 504–504. 27 indexed citations

11.

Lesurf, Robert, Obi L. Griffith, Malachi Griffith, et al.. (2017). Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial. Annals of Oncology. 28(5). 1070–1077. 47 indexed citations

12.

Yu, Jinsheng, Hrishikesh Deshmukh, Jacqueline E. Payton, et al.. (2011). Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor. Clinical Cancer Research. 17(7). 1924–1934. 85 indexed citations

13.

Crowder, Robert J., Chanpheng Phommaly, Tao Yu, et al.. (2009). PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer. Cancer Research. 69(9). 3955–3962. 174 indexed citations

14.

Ellis, Matthew J., Lin Li, Robert J. Crowder, et al.. (2009). Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. Breast Cancer Research and Treatment. 119(2). 379–390. 110 indexed citations

15.

Sanati, Souzan, Mark A. Watson, Andrea L. Salavaggione, & Peter A. Humphrey. (2009). Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate. Modern Pathology. 22(10). 1273–1279. 38 indexed citations

16.

Song, Haengseok, Bo Zhang, Mark A. Watson, et al.. (2009). Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene. 28(37). 3307–3319. 78 indexed citations

17.

Watson, Mark A., Lourdes R. Ylagan, Kathryn Trinkaus, et al.. (2007). Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies TWIST1 as a Marker of Early Tumor Relapse in Breast Cancer Patients. Clinical Cancer Research. 13(17). 5001–5009. 98 indexed citations

18.

Miller, Shyra J., Fatima Rangwala, Jon Williams, et al.. (2006). Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues. Cancer Research. 66(5). 2584–2591. 158 indexed citations

19.

Jain, Sanjay, Mark A. Watson, Mary K. DeBenedetti, et al.. (2004). Expression Profiles Provide Insights into Early Malignant Potential and Skeletal Abnormalities in Multiple Endocrine Neoplasia Type 2B Syndrome Tumors. Cancer Research. 64(11). 3907–3913. 59 indexed citations

20.

Watson, Mark A. & Timothy P. Fleming. (1996). Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer.. PubMed. 56(4). 860–5. 263 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact